0-10 importance and confidence rulers, 278 25(OH)D, 245, 246 A AAP. See American Academy of Pediatrics (AAP) Abdominal ultrasound, 244 Academy of Nutrition and Dietetics, 296 Acarbose, 414 Accelerometer, 323, 329 ACEI. See Angiotensin-converting enzyme inhibitor (ACEI) Acoustic radiation force imaging, 244 Action reflections, 273, 274t Activity logs, 323 Activity monitors, 302 Adenotonsillar hypertrophy, 350, 352 Adenotonsillectomy, 352–353 Adipocyte protein 2 (aP2), 398 Adiponectin (ADIPOQ), 397 Adjustable gastric band, 225–226 Adrenarche, 368 Adrenocortical insufficiency, 433 African Americans. See Race and ethnicity Agouti-related peptide (AGRP), 380, 381f Alanine aminotransferase (ALT), 237, 241t, 242, 243, 336, 337t, 338, 340 Albright hereditary osteodystrophy, 234f, 235, 388t Albuminuria, 434 Alcohol, 418, 437–438 ALMS1 gene, 234 ALMS1 syndrome, 396 Alpha-1 antitrypsin deficiency, 244t, 337t Alpha-glucosidase inhibitors, 414 a-MSH, 380 Alström syndrome, 234, 234f, 388t ALT. See Alanine aminotransferase (ALT) Ambulatory blood pressure testing, 345 American Academy of Pediatrics (AAP) annual wellness examination, 327 eating disorders, 216–217 IHELLP Social History Questions, 217, 218t patient-centered communication styles, 305 routine health screening, 322 screen time use, 213–214 snoring, 215 American’s Best Health Plans, 322 Amplified negative reflections, 274t Amylin receptor agonists, 414 Angiotensin-converting enzyme inhibitor (ACEI), 348 Angiotensin receptor blocker, 348 Animas OneTouch Ping, 450t Animas Vibe, 450t Antihyperglycemic therapies, 414 aP2. See Adipocyte protein 2 (aP2) Apneas, 351 Apps health and fitness, 221–222 weight-focused, 287, 301–303 Aromatase, 364, 364f Aromatization of androgens, 364, 364f Artificial pancreas, 446, 455–457 Ask-tell-ask, 280 Aspartate aminotransferase (AST), 237, 241t, 242 AST. See Aspartate aminotransferase (AST) Atkins diet, 290 Attribution theory, 258 Atypical diabetes mellitus, 426t Autoimmune hepatitis, 244t, 337t AutoSyringe, 446 B Bannayan-Riley-Ruvalcaba syndrome, 391t Bardet-Biedl syndrome (BBS), 234f, 235, 386, 388–389t Bariatric surgery, 225–226, 246, 340, 395, 414–415 Basal-bolus insulin injection, 447–448, 448f Basal insulin therapy, 411 BBS. See Bardet-Biedl syndrome (BBS) BBS genes, 235 BDMR. See Brachydactyly mental retardation syndrome (BDMR) BDNF. See Brain-derived neurotrophic factor (BDNF) BDNF mutations, 382t, 384 BEARS instrument, 215 Beckwith-Wiedemann syndrome, 391t Behavioral Risk Factor Surveillance System, 323 Behavioral weight loss intervention programs frequent self-weighing, 304–305 mindful eating, 297–298 more intensive intervention model, 288 Adolesc Med 028 (2017) 461–476 Note: Page numbers of articles are in boldface type. Page references followed by “f and “t denote figures and tables, respectively. AMSTARs_Fall-2017_13_IDX_461-482.indd 461 8/3/17 3:45 PM
Previous Page Next Page